Antitumour Activity of Rezatapopt Provides Proof of Concept for p53 Reactivation in Patients with TP53 Y220C-mutated Solid Tumours / ESMO

esmo - Findings from the PYNNACLE study

#healthcare #pharmaceuticals #biotech #drugdevelopment #oncology

Rezatapopt Shows Early Activity in TP53 Y220C–Mutated Solid Tumors

7 days / oncodaily

Targeting the untargetable cancer—rezatapopt, an oral p53 reactivator

9 days / medicalxpress

Antitumour Activity of Rezatapopt Provides Proof of Concept for p53 Reactivation in Patients with TP53 Y220C-mutated Solid Tumours

9 days / esmo

Jayastu Senapati: Trial of Rezatapopt in TP53-Y220C Mutated MDS/AML

10 days / oncodaily

Rashid Lui: First-in-Class Oral Selective p53 Reactivator Looks Promising

11 days / oncodaily

Xin Lu on Targeting Mutant p53 in Solid Tumors with Rezatapopt – NEJM Group

11 days / oncodaily

Florent Peyraud: Restoring Function to a Variant of p53 in Solid Tumors

12 days / oncodaily

Aydah AlAwadhi: Targeting the “Undruggable” p53 – A Long Awaited Proof of Principle

12 days / oncodaily

Monday, March 2, 2026, 2:22 am / permalink 19973 / 8 stories in 9 days

Related Stories

Related Tags

Healthcare

Judge orders Leapfrog to remove safety grades for five Florida hospitals (21 hrs)

Daily multivitamin slows epigenetic aging in randomized COSMOS analysis (40 hrs)

White House briefing triggered rapid drops in acetaminophen use in ERs (2 days)

more #healthcare

Pharmaceuticals

Engineered CAR‑T cells secreting VEGF‑neutralizing scFvs boost solid‑tumor activity (2 days)

White House briefing triggered rapid drops in acetaminophen use in ERs (2 days)

Eli Lilly launches Employer Connect to broaden GLP‑1 coverage (3 days)

more #pharmaceuticals

Biotech

Engineered CAR‑T cells secreting VEGF‑neutralizing scFvs boost solid‑tumor activity (2 days)

Cancer Grand Challenges awards five teams bold funding for cancer research (3 days)

Belzutifan combinations highlighted at ASCO GU improve RCC outcomes (4 days)

StackHealth Time Machine

NorthFeed Inc.

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.